NCT04699058View on ClinicalTrials.gov

COVID-19 Sero-prevalence Health Care Workers Kinshasa

CompletedOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
SARS-CoV InfectionSeroprevalence
Interventions
DIAGNOSTIC_TEST

COVID-antibody test

Questionnaire and COVID-antibody test for all participants

Trial Locations (1)

Unknown

Institut Nationale de recherche Biomédicale, Kinshasa

All Listed Sponsors
collaborator

Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

OTHER

lead

Institute of Tropical Medicine, Belgium

OTHER

NCT04699058 - COVID-19 Sero-prevalence Health Care Workers Kinshasa | Biotech Hunter | Biotech Hunter